Venable Fitzpatrick successfully defended the validity of a compound patent covering Sanofi’s Jevtana (cabazitaxel) chemotherapy product before the Federal Circuit. Venable Fitzpatrick also succeeded in vacating…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now